No Evidence of Microsatellite Instability in Head and Neck Squamous Cell Carcinoma of Non‐Smokers and Non‐Drinkers
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von F J Mulder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head & Neck Surgery, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Cente…. Hauptthemen laut MEDLINE: Microsatellite Instability, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
While the prevalence of microsatellite instability (MSI) is low in the whole head and neck squamous cell carcinoma (HNSCC) population, it has been suggested to be more prominent in tumors of non‐smokers. Therefore, the goal of this study was to determine the presence of MSI in a cohort of well‐defined HNSCC of non‐smokers and non‐drinkers (NSND).
Methods
Clinical characteristics and tumor tissue of 119 NSND with HNSCC were retrospectively collected and analyzed for MLH1, PMS2, MSH2, and MSH6 protein expression on tissue microarrays (TMA). In case of negative staining for one of these mismatch repair proteins in the TMA cores, immunohistochemistry (IHC) was repeated on a whole slide section and additional molecular analyses were performed using polymerase chain reaction (PCR) and quantitative PCR (qPCR).
Results
Two cases showed dubious loss of MSH2 expression, one of these with concurrent dubious loss of MSH6 on the TMA. However, MSH2 and MSH6 expression was retained on whole slide sections and PCR and qPCR analyses did not show any mutations, compatible with a microsatellite stable result.
Conclusion
This study shows no single case with MSI in the NSND subgroup of HNSCC. Although a deficient DNA mismatch repair system is a predictive biomarker for response to immune checkpoint inhibitors, we found no evidence to support routine analysis of MSI in HNSCC, also not in the subgroup of NSND.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head & Neck Surgery, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.
- Department of Otorhinolaryngology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Pathology, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.
- Department of Otorhinolaryngology and Head & Neck Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
ORCID-Profile: F J Mulder, T F B Gielgens, R de Bree
Zitieren
APA
Mulder, F. J., Gielgens, T. F. B., de Ruiter, E. J., de Bree, R., van den Hout, M. F. C. M., Kremer, B., Willems, S. M., & Speel, E. J. M. (2026). No Evidence of Microsatellite Instability in Head and Neck Squamous Cell Carcinoma of Non‐Smokers and Non‐Drinkers. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70120
Vancouver
Mulder FJ, Gielgens TFB, de Ruiter EJ, de Bree R, van den Hout MFCM, Kremer B, et al. No Evidence of Microsatellite Instability in Head and Neck Squamous Cell Carcinoma of Non‐Smokers and Non‐Drinkers. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70120
BibTeX
@article{Mulder2026,
author = {Mulder, F J and Gielgens, T F B and de Ruiter, E J and de Bree, R and van den Hout, M F C M and Kremer, B and Willems, S M and Speel, E J M},
title = {No Evidence of Microsatellite Instability in Head and Neck Squamous Cell Carcinoma of Non‐Smokers and Non‐Drinkers},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70120}
}
EUVIMED